|
Frozen
section investigation of the sentinel node in malignant melanoma
and breast cancer.
Tanis PJ, Boom RP, Koops HS, et al. Ann Surg Oncol. 2001;8:222-6.
In
vitro high-resolution helical CT of small axillary lymph nodes
in patients with breast cancer: correlation of CT and histology.
Uematsu T, Sano M, Homma K. AJR Am J Roentgenol. 2001;176:1069-74.
Lymphatic
Mapping of the Breast: Locating the Sentinel Lymph Nodes.
Uren RF, Howman-Giles R, Renwick SB, Gillett D. World J Surg.
2001;25:789-793.
Extensive
Frozen Section Examination of Axillary Sentinel Nodes to Determine
Selective Axillary Dissection.
Veronesi U, Zurrida S, Mazzarol G, Viale G. World J Surg.
2001;25:806-808.
Sentinel
node biopsy with technetium-99m colloidal rhenium sulphide
in patients with breast cancer.
Watanabe T, Kimijima I, Ohtake T, Tsuchiya A, Shishido F,
Takenoshita S. Br J Surg. 2001;88:704-7.
Lymphoscintigraphy
in breast cancer: the value of breast lymphoscintigraphy in
breast sentinel node staging.
Wong JH, Steinemann S, Jehoon Ko P, Wong DL. Clin Nucl Med.
2001;26:502-5.
Predicting
the Status of the Nonsentinel Axillary Nodes: A Multicenter
Study.
Wong SL, Edwards MJ, Chao C, et al. Arch Surg. 2001;136:563-568.
Dermal
versus intraparenchymal lymphoscintigraphy of the breast.
Shen P, Glass EC, DiFronzo LA, Giuliano AE. Ann
Surg Oncol. 2001;8:241-8.
Lymphoscintigraphic
sentinel node imaging and gamma probe detection in breast
cancer with Tc-99m nanocolloidal albumin: results of an optimized
protocol.
Rink
T, Heuser T, Fitz H, Schroth HJ, Weller E, Zippel HH.
Clin
Nucl Med. 2001;26:293-8.
Learning
curves and breast cancer lymphatic mapping: institutional
volume index.
Dupont
E, Cox C, Shivers S, et al. J Surg Res. 2001;97:92-6.
Comparison
of intradermal and subcutaneous injections in lymphatic mapping.
Kersey TW, Van Eyk J, Lannin DR, Chua AN, Tafra L. J Surg
Res. 2001;96:255-9.
Is
Lymphatic Mapping in Breast Cancer Adequate and Safe?
Nieweg
OE, Rutgers EJ, Jansen L, et al. World
J Surg. 2001;25:780-788.
The
role of lymphoscintigraphy in the management of the patient
with breast cancer.
Dupont EL, Kamath VJ, Ramnath EM, et al. Ann Surg Oncol. 2001;8:354-60.
Axillary
Dissection over the Years: Where To from Here?
Keshtgar MR, Baum M. World J Surg. 2001;25:761-766.
Intraoperative
pathologic evaluation of a breast cancer sentinel lymph node
biopsy as a determinant for synchronous axillary lymph node
dissection.
Kane JM 3rd, Edge SB, Winston JS, Watroba N, Hurd TC. Ann
Surg Oncol. 2001;8:361-7.
The
effects of postinjection massage on the sensitivity of lymphatic
mapping in breast cancer. Journal of the American College
of Surgeons.
Bass
SS, Cox CE, Salud CJ, et al. 192(1):9-16, 2001 Jan.
Intradermal
isotope injection: A highly accurate method of lymphatic mapping
in breast carcinoma.
Boolbol SK, Fey JV, Borgen PI, et al. Annals of Surgical Oncology.
8(1):20-24, 2001 Jan-Feb.
Complementarity
of blue dye and isotope in sentinel node localization for
breast cancer: Univariate and multivariate analysis of 966
procedures.
Cody
HS, Fey J, Akhurst T, et al. Annals
of Surgical Oncology. 8(1):13-19, 2001 Jan-Feb.
The
potential value of intraoperative imprint cytology of axillary
sentinel lymph nodes in breast cancer patients.
Cserni G. American Surgeon. 67(1):86-91, 2001 Jan.
Detection,
treatment and outcome of axillary recurrence after axillary
clearance for invasive breast cancer.
de Boer R, Hillen HFP, Roumen RMH, Rutten HJT, van der Sangen
MJC, Voogd AC. British Journal of Surgery. 88(1):118-122,
2001 Jan.
The
use of sentinel lymphadenectomy to identify candidates for
postoperative adjuvant therapy of melanoma and breast cancer
[Review].
Habal N, Giuliano AE, Morton DL. Seminars in Oncology. 28(1):41-52,
2001 Feb.
A
new radiocolloid for sentinel node detection in breast cancer.
Hodgson N, Zabel P, Mattar AG, Engel CJ, Girvan D, Holliday
R. Annals of Surgical Oncology. 8(2):133-137, 2001 Mar.
Non-visualization
of sentinel lymph node in patients with breast cancer.
Krausz Y, Ikeda DM, Jadvar H, Langleben D, Birdwell R, Strauss
HW. Nuclear Medicine Communications. 22(1):25-32, 2001 Jan.
Endoscopic
axillary lymphadenectomy without prior liposuction in 100
patients with invasive breast cancer.
Malur S, Bechler J, Schneider A. Surgical Laparoscopy, Endoscopy
& Percutaneous Techniques. 11(1):38-41, 2001 Feb.
Axillary
lymph node status of T-1 primary breast cancer in a diverse
population.
Madan AK, Macareo L, Winfrey K, Beech DJ. American Surgeon.
67(1):71-74, 2001 Jan.
Sentinel
lymph node biopsy in breast cancer patients: subdermal versus
peritumoural radiocolloid injection.
Mateos JJ, Vidal-Sicart S, Zanon G, et al. Nuclear Medicine
Communications. 22(1):17-24, 2001 Jan.
Combination
technique is superior to dye alone in identification of the
sentinel node in breast cancer patients.
Motomura
K, Inaji H, Komoike Y, et al.Journal
of Surgical Oncology. 76(2):95-99, 2001 Feb.
Sentinel
lymph node biopsy as an alternative to routine axillary lymph
node dissection in breast cancer patients [Review].
Noguchi M. Journal of Surgical Oncology. 76(2):144-156, 2001
Feb.
Sentinel
lymph node biopsy in patients with male breast carcinoma.
Port ER, Fey JV, Cody HS, Borgen PI. Cancer. 91(2):319-323,
2001 Jan 15.
Lymph
nodes in the human female breast: A review of their detection
and significance [Review].
Schmidt WA, Boudousquie AC, Vetto JT, et al. Human Pathology.
32(2):178-187, 2001 Feb.
Sentinel-node
biopsy in axillary lymph-node staging for patients with multicentric
breast cancer.
Schrenk P, Wayand W. Lancet. 357(9250):122, 2001 Jan 13.
Systemic
treatment after sentinel lymph node biopsy in breast cancer:
Who, what, and why? [Review].
Singletary SE. Journal of the American College of Surgeons.
192(2):220-230, 2001 Feb.
Multicenter
trial of sentinel node biopsy for breast cancer using both
technetium sulfur colloid and isosulfan blue dye.
Tafra
L, Lannin DR, Swanson MS, et al. Annals
of Surgery. 233(1):51-59, 2001 Jan.
Anatomy
and physiology of lymphatic drainage of the breast from the
perspective of sentinel node biopsy [Review].
Tanis PJ, Nieweg OE, Olmos RAV, Kroon BBR. Journal of the
American College of Surgeons. 192(3):399-409, 2001 Mar.
Fusion
lymphoscintigraphy with a 24-hour Tc-99m MDP bone scan for
sentinel lymph node detection and imaging.
Tatini
VR, Dworkin HJ. Clinical Nuclear Medicine. 26(1):53, 2001 Jan.
Biopsy
of sentinel lymph nodes guided by lymphoscintigraphic mapping
in patients with breast cancer.
Tuthill LL, Reynolds HE, Goulet RJ. American Journal of Roentgenology.
176(2):407-411, 2001 Feb.
Sentinel
lymph node biopsy in breast cancer: Creating controversy and
defining new standards [Review].
Weaver DL. Advances in Anatomic Pathology. 8(2):65-73,
2001 Mar.
Lymphovascular
invasion enhances the prediction of non-sentinel node metastases
in breast cancer patients with positive sentinel nodes.
Weiser MR, Montgomery LL, Tan LK, et al. Annals of Surgical
Oncology. 8(2):145-149, 2001 Mar.
Lymphoscintigraphy and sentinel node localization in breast
cancer patients: A comparison between 1-day and 2-day protocols.
Yeung
HWD, Cody HS, Turlakow A, et al. Journal of Nuclear Medicine.
42(3):420-423, 2001 Mar.
Preoperative
lymphoscintigraphy and sentinel lymph node biopsy in papillary
thyroid cancer.
Catarci
M, Zaraca F, Angeloni R, et al. A
pilot study. J Surg Oncol. 2001;77:21-4; discussion 25.
Axillary
Node Sample to Evaluate the Axilla.
ChettyCh B U. World J Surg. 2001;25:773-779.
Sentinel
Node Biopsy in Breast Cancer: ALMANAC Trial.
Clarke
D, Khonji NI, Mansel RE. World
J Surg. 2001;25:819-822.
Revolutionary
impact of lymphoscintigraphy and intraoperative sentinel node
mapping in the clinical practice of oncology.
Czerniecki BJ, Bedrosian I, Faries M, Alavi A. Semin Nucl
Med. 2001;31:158-64.
Gamma
probe sentinel node localization and biopsy in breast cancer
patients treated with a neoadjuvant chemotherapy scheme.
Fernandez
A, Cortes M, Benito E, et al. Nucl
Med Commun. 2001;22:361-6.
Is
There a Role for Selective Axillary Dissection in Breast Cancer?
Gemignani ML, Borgen PI. World J Surg. 2001;25:809-818.
Radiolabeled
Sentinel Node Biopsy: Collaborative Trial with the National
Cancer Institute.
Krag DN, Harlow S, Weaver D, Ashikaga T. World J Surg. 2001;25:823-828.
National
practice patterns of sentinel lymph node dissection for breast
carcinoma.
Lucci A Jr, Kelemen PR, Miller C 3rd, Chardkoff L, Wilson
L. J Am Coll Surg. 2001;192:453-8.
Dermal
injection of radioactive colloid is superior to peritumoral
injection for breast cancer sentinel lymph node biopsy: results
of a multiinstitutional study.
McMasters KM, Wong SL, Martin RC 2nd, et al. Ann
Surg. 2001;233:676-87.
|
